Glioblastoma is a devastating diagnosis, typically offering patients a mere 15 months to live.

The malignant nature of glioblastoma, spreading rapidly through the brain, has long posed a significant challenge in finding effective treatment options.

Our PhD student, Yanti de Visser, has been working on a personalized approach to slow down the progression of this aggressive brain tumor. . The initial findings suggest that our personalized treatment approach has the potential to extend patients' lives by years rather than months.

While further research is essential to validate these early results, the progress made so far marks a significant stride in the quest for more effective glioblastoma treatments. We remain committed to advancing medical science, bringing hope to patients and their families.